Canopy Biosciences logo

Canopy Biosciences

Providing access to cutting-edge spatial biology and multi-omic tools.

26 employees · est. 2016 · United States

VS
Vizgen logo

Vizgen

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis

153 employees · est. 2019 · Cambridge, United States

Canopy Biosciences is the older company (2016 vs 2019); Vizgen is the larger of the two.

Side-by-Side Comparison

Canopy Biosciences Vizgen
Founded
2016 older 2019
Headquarters
United States Cambridge, United States
Employees
26 153 larger
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series Unknown Series E
Total Funding
$4.40M $184.20M
Funding Rounds
3 5
Services
Not tracked yet Spatial Transcriptomics Services, Spatial Proteomics Services, Spatial Omics Services, Custom Biomarker Panels, Data Analysis with STARVUE
Target Customers
Not tracked yet Molecular Labs, Researchers in Neuroscience, Oncology Researchers, Immunology Researchers, Academic Institutions, Biotech Companies
Taxonomy
Spatial Biology, Multi-omic Tools, Gene Editing, Personalized Medicine, Transcriptomics, CLIA, CRO Services, Multiplex Imaging, Digital Pathology, Immunofluorescence, Tissue Analysis, Proteomics, Spatial Phenotyping Single-cell Spatial Genomics, Spatial Multiomics, MERFISH Technology, MERSCOPE Platform, InSituPlex Assays, AI-driven Spatial Image Analysis, Translational Research, High-fidelity Data, Quantitative Data Analysis, Spatial Biology, Multi-omics Research, Genome-scale Nucleic Acid Imaging, Subcellular Resolution, Drug Development, Biotech Innovation
Website
canopybiosciences.com vizgen.com
Canopy Biosciences logo

About Canopy Biosciences

Canopy Biosciences is a biotech startup that aims to revolutionize the field of spatial biology and multi-omic tools. Acquired by Bruker, the company is driven by its mission to empower innovation by providing biomedical researchers with cutting-edge technologies to accelerate scientific discovery....

Vizgen logo

About Vizgen

Vizgen, a frontrunner in the spatial biology sector, is making waves with its innovative MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics. Following its merger with Ultivue, the company has positioned itself at the forefront of spatial multiomics analysis, integrati...

We will tell you when either one moves

BounceWatch watches Canopy Biosciences and Vizgen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Canopy Biosciences and Vizgen — by email.

Frequently Asked Questions

Canopy Biosciences — Providing access to cutting-edge spatial biology and multi-omic tools.. Vizgen — Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Canopy Biosciences has raised $4.40M while Vizgen has raised $184.20M.
Canopy Biosciences and Vizgen operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Canopy Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Canopy Biosciences on 12 Sep 2024, and Vizgen on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy